Low IL-35 expression in CSF is associated with Neuro-Behcet Disease: Comparative analysis between parenchymal and Non-parenchymal NBD
- 11 May 2025
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 275, 107031
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Interleukin 37; a possible marker of arterial stiffness in Behçet's diseaseThe American Journal of the Medical Sciences, 2022
- Interleukin-36: Structure, Signaling and Function2020
- IL-1β blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based reviewRheumatology International, 2019
- Emerging role of IL-35 in inflammatory autoimmune diseasesAutoimmunity Reviews, 2018
- Up-regulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signaling in the rat spinal cord after tetanic sciatic stimulationBrain, Behavior, and Immunity, 2014
- Neuro-Behçet syndrome2014
- Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendationsJournal of Neurology, 2013
- Production and functions of IL-33 in the central nervous systemBrain Research, 2011
- CSF levels of cytokines in neuro-Behçet's diseaseClinical Neurology and Neurosurgery, 2009
- Beh et's disease: diagnostic and prognostic aspects of neurological involvementJournal of Neurology, 2001